Clinical Trial Update: A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 [Phase 1, Phase 2]

View source ↗

Summary

A randomized, double-blind, placebo-controlled study assessing antimicrobial efficacy and safety of topical DPK-060 in atopic dermatitis completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DPK-060

Snippet

Sponsor: DermaGen AB | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-12-05